IRVINE, Calif., Nov. 26, 2008 (GLOBE NEWSWIRE) -- SenoRx (Nasdaq:SENO) today announced its participation at the annual congress of the Radiological Society of North America (RSNA). RSNA is the largest meeting for radiologists in the world, with more than 60,000 medical and science professionals from around the globe expected to attend the largest medical meeting in North America. RSNA will be held November 30 through December 5, 2008, at the McCormick Place Convention Center in Chicago. SenoRx will showcase its products at North Building Hall B Booth #8920 and will also participate in four MRI biopsy workshops and one ultrasound biopsy workshop. SenoRx biopsy products will also be displayed at booths for GE Healthcare in the South Building Hall A (#5529 and #4839), Siemens in the Lakeside Center Hall D (#922) and Giotto in South Building Hall A (#6206).
"SenoRx is pleased to again participate for the eighth year at RSNA, which offers an excellent opportunity for us to showcase our EnCor(r) Breast Biopsy System for MRI and the novel VisiLoc(tm) MRI visible obturator, now available in both 10G and 7G size probes and introducers," said Lloyd Malchow, SenoRx President and Chief Executive Officer. "Our participation in the workshops will provide a hands-on opportunity for radiologists to experience the capabilities and performance for MRI and ultrasound that our EnCor Breast Biopsy System offers. Also, we are excited to demonstrate the flexibility of the EnCor Breast Biopsy System with its ability to optimally interface with the state-of-the-art in imaging modalities."
About SenoRx
SenoRx (Nasdaq:SENO) develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its EnCor(r) vacuum-assisted breast biopsy system and Contura(tm) MLB catheter for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer. SenoRx's field sales organization serves over 1,000 breast diagnostic and treatment centers in the United States and Canada. In addition, SenoRx sells several of its products through distributors in more than 20 countries outside the U.S. and Canada. The company's line of breast care products includes biopsy disposables, biopsy capital equipment, diagnostic adjunct products and therapeutic disposables. SenoRx is developing additional minimally invasive products for the diagnosis and treatment of breast cancer. For more information, visit the company's website at www.senorx.com.
The SenoRx, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3605